RBDCOV Talks is a ten-episode series where RBDCOV's leading scientists, researchers, medical professionals and community advocates will take us on a knowledge-packed journey to explore and discuss the world of vaccine clinical trials. In these episodes, we will understand how vaccine clinical trials work and talk through interesting topics such as inclusion criteria in a vaccine clinical trial, personalised vaccines and what exactly immunological memory is.
In 5 minutes, what is a recombinant protein vaccine?
🧬Dive into the world of recombinant protein vaccines in just 10 minutes with Antonio Barreiro from HIPRA. Unveil the science behind this innovative approach to HIPRA’s vaccine development.
What’s Drug Safety? What is Drug Safety-level safety monitoring like in vaccine clinical trials?
Discover the critical role of Drug Safety in vaccine trials with Helena Belinchon from ASPHALION. 🩺 How do experts ensure safety at every level? Join the safety journey now! 🌟💊
All about vaccine clinical trials: what are they and how do they work?
Explore the intricate world of vaccine clinical trials with Montse Barceló from VERISTAT. 🧪 What are they, and how do they shape the future of healthcare?
All about immunological memory: what is it, how is it obtained and what is the result?
Unveil the vital role of immunological memory, the key to long-lasting, protective immunity with Pere Soler Palacin from Vall D'Hebron. Understand why vaccinations earn immense respect in the scientific community for bolstering our defenses against infectious diseases. 🌐💪
Why have paediatric and adolescent participants been included in this trial?
Explore the significance of including the youngest in vaccine trials with Pablo Rojo from PENTA. Join us as we discuss the impact on child health and the broader community. 🌍💉
Why should people living with HIV and other immunocompromising conditions be included in clinical trials similar to the RBDCOV trial?
Shed light on immunocompromised clinical trials inclusion. 🦠 Why involve those with HIV?
Join our conversation with Juanfran C and Arda from EATG to understand better the significance for a more inclusive and effective future.